tiprankstipranks
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market
MDNAF
Medicenna Therapeutics Corp
RESEARCH TOOLSreports

Medicenna Therapeutics Corp (MDNAF) Stock News & Sentiment

253 Followers
Medicenna Taps Pembrolizumab Veteran as CMO to Steer Superkine Immunotherapy Pipeline
Premium
Company Announcements
Medicenna Taps Pembrolizumab Veteran as CMO to Steer Superkine Immunotherapy Pipeline
1d ago
Medicenna to Showcase First-in-Class Tumor-Targeted PD-1 x IL-2 Superkine at AACR 2026
Premium
Company Announcements
Medicenna to Showcase First-in-Class Tumor-Targeted PD-1 x IL-2 Superkine at AACR 2026
23d ago
Medicenna to Spotlight Superkine Oncology Pipeline at Global Investor and Scientific Conferences
Premium
Company Announcements
Medicenna to Spotlight Superkine Oncology Pipeline at Global Investor and Scientific Conferences
2M ago
Medicenna Refreshes Board With Capital Markets and Biotech Leadership Expertise
Premium
Company Announcements
Medicenna Refreshes Board With Capital Markets and Biotech Leadership Expertise
2M ago
MDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Medicenna Maps 2026 Milestones as IL-2 Superkine MDNA11 Delivers Promising Cancer Responses
Premium
Company Announcements
Medicenna Maps 2026 Milestones as IL-2 Superkine MDNA11 Delivers Promising Cancer Responses
3M ago
Medicenna Targets Pivotal 2026 as IL-2 Superkine Programs Advance Toward Registrational Trials
Premium
Company Announcements
Medicenna Targets Pivotal 2026 as IL-2 Superkine Programs Advance Toward Registrational Trials
3M ago
More MDNAF News >

MDNAF News on the Web

Medicenna Taps Pembrolizumab Veteran as CMO to Steer Superkine Immunotherapy Pipeline
TipRanks News
Neutral
Medicenna to Showcase First-in-Class Tumor-Targeted PD-1 x IL-2 Superkine at AACR 2026
TipRanks News
Neutral
Medicenna Refreshes Board With Capital Markets and Biotech Leadership Expertise
TipRanks News
Bearish
Medicenna Therapeutics reports Q3 EPS (5c) vs. (7c) last year
TipRanks News
Bullish
Medicenna Therapeutics sees cash runway into 3Q26
TipRanks News
Neutral
Medicenna Therapeutics appoints Richard Sutin, Angelos Georgakis to board
TipRanks News
Neutral
MDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks News
Neutral
Medicenna Maps 2026 Milestones as IL-2 Superkine MDNA11 Delivers Promising Cancer Responses
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
MDNAF
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MDNAF’s Media Buzz Sentiment?
1 articles about MDNAF were published this week. In an average week, 1 articles are published.
    What is MDNAF’s weekly average amount of articles?
    In an average week, 1 articles about MDNAF are published.
      What is MDNAF’s News Sentiment?
      50% of articles about MDNAF were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        OWLTOwlet
        IVVDInvivyd
        Showing the stocks with the most bullish news sentiment over the past week